Washington (AP) – President Donald Trump says that he will sign an executive order on Monday, which, if it is implemented, will reduce the costs of some medication and revive a failed effort from his first term on a topic that he has been upset before the president since his presidency.
The order that Trump promises will make the Ministry of Health and Human Services connecting what Medicare pays for medication that is managed in a doctor’s office at the lowest price that other countries have paid.
“I will set up a most preferred national policy in which the United States pay the same price as the nation that pays the lowest price everywhere in the world,” the President recorded on Sunday on his social media website and promised to sign the order in the White House on Monday morning.
“Our country is finally treated fairly, and the health costs of the citizens are reduced by numbers that have never been thought of before,” added Trump.
His proposal would probably only affect certain drugs that are covered by Medicare and administered in an office – think of infusions that treat cancer and other injectable games. But it could possibly bring significant savings for the government, although the Trump billion dollars, which praised in its post, may be exaggerated.
Medicare offers health insurance for around 70 million older Americans. Complaints about the US medicinal products prices that are notoriously high, even compared to other huge and wealthy countries, have long broken the anger of both parties, but a indefinite solution has never released the congress.
According to the planned order, the Federal Government would combine what it pays for the medicines for these medication, at the price of a group of other economically advanced country -like “most preferred nation” approach.
The proposal will be exposed to violent resistance to the pharmaceutical industry.
It was a rule that Trump tried to adopt during his first term, but could never get through. In the last few weeks of his presidency, he signed a similar executive order, but a court regulation later blocked that the rule came into force after the bid administration.
The pharmaceutical industry argued that Trump’s attempt by Trump would give foreign governments the “upper hand” to decide the value of medication in the USA. The industry has long argued that the enforcement of lower prices will impair profits and ultimately influence innovation and its efforts to develop up-to-date medication.
Only medication for Medicare Part B – insurance for visits to the doctor’s office – should be covered. The beneficiaries of Medicare are responsible for capturing some of the costs for obtaining these medication during the doctor’s visits, and there is no annual upper limit for time-honored Medicare participants.
A report by the Trump administration during its first term showed that the United States spends twice as much as in some other countries when covering these medication. Medicare part B The pharmaceutical expenditure exceeded 33 billion US dollars in 2021.
More habitual prescription drugs that are subject to a pharmacy are probably not covered by the up-to-date order.
Trump’s contribution in the preview of the campaign officially came after he teased a “very big announcement” last week. He did not indicate any details, except not to notice that it was not associated with the trade or tariffs that he imposed on a huge part of the world.
“We will make a very, very large announcement – as the big thing as possible,” said Trump last week.
He came into his first term in which he accused pharmaceutical companies “to get away with murder” and complained that other countries whose governments set the drug prices explained.
On Sunday, Trump again aimed at the industry and wrote that the “drug/pharmaceutical companies would say for years that it was research and development costs and that all these costs alone would be borne by the ‘Suckers’ of America.
With reference to the mighty lobby efforts by the drugstores, he said that campaign contributions can “do miracles, but not with me and not with the Republican party”.
“We’ll do the right thing,” he wrote.
